European Medicines Agency Recommends Withdrawal Of Marketing Authorisations For Cough Medicines Containing Clobutinol

Finalising a review of the safety of clobutinol-containing cough medicines in the European Union (EU), the European Medicines Agency (EMEA) concluded that the risks of these medicines are greater than their benefits and recommended that the marketing authorisations for these medicines be withdrawn throughout the EU. [click link for full article]

More: continued here

Filed under: Pharma Industry on October 20th, 2007